The 10 Most Unanswered Questions about

Benefits and Shortcomings of Mammography Screening

Although it has its side effects, mammography screening is a program offered at a certain cost and in intervals, and is designed for the purpose of early cancer detection which assists in lowering the rates of deaths and also improving therapeutic options. As of now, it is the only method that has been proved to meet the above needs. Starting with the advantages, the following paragraphs will expound on 3 of the benefits of mammography screening and 3 of its shortcomings.
To begin with, the first advantage of this screening is that it reduces the mortality rate although it will be well evaluated years from now since it is hard to assess it for this one type of cancer when all cancers kill during the advanced stages. Mortality reduction is currently estimated between 15% to 30% in a study where 70% of the women did not participate in the program and it is estimated to exceed 35% for those participating.
The second advantage is that of improvement the chances of treating early disease which comes as a result of early detection that enhances low mastectomies number, better results from breast conservation and reduced chemotherapy.
Lastly, there has been an improvement on the quality assurance of the diagnostic chain seeing that proper infrastructure is being implemented to address a problem that arose where detection happened with no subsequent assessments and diagnosis hence enhancing more collaboration and cooperation between disciplines. read more now
To begin on the shortcomings, the first is that mammography exposes the women to risks of radiation and other risks with the digital mammography techniques offering a dosage of 4mGy per breast, whose effect however decreases with the increase in age, as women beyond 40 years have less chances of dying due to breast cancer.
The second shortcoming of this program is that there is a risk of a false alarm, where, like all medical tests, mammography screening may sense abnormalities which ask for further assessment and still turn out to be benign, yet only few women are recalled to take the screen again meaning that they may take the false alarm with them as the results.
Lastly, there the risk of over diagnosis whereby some additional cancers detected may not have come to affect the person if the screening was not done and detecting them does not reduce death rates and this can be proved by the fact that a screened population of the same composition and age tend to have more breast cancers than the unscreened population with the same composition and age.